Health

INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent

SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare…

10 months ago

Akari Therapeutics Releases Virtual Investor What This Means Segment Highlighting its Recently Granted India Patent

June 25, 2025 09:00 ET  | Source: Akari Therapeutics Plc Access the “What This Means” segment here BOSTON and LONDON,…

10 months ago

Femasys Announces Historic Milestone with European Approval of FemBloc, the First Non-Surgical Permanent Birth Control

ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in…

10 months ago

Clariane has successfully completed a bond issue of 400 million euros

Press release June 24, 2025  Clariane has successfully completed a bond issue in the amount of 400 million euros Paris, June…

10 months ago

CROSSJECT announces a successful capital increase of 5.7 million following full exercise of the extension clause

Press release CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause Transaction raised…

10 months ago

Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse

Lulutox Detox Tea officially launches across Ireland, the USA, UK, Australia and Canada. Formulated with natural herbs like dandelion, fennel,…

10 months ago

Lyell Immunopharma to Participate in the H.C. Wainwright HCW@Home Series

June 23, 2025 17:00 ET  | Source: Lyell Immunopharma, Inc SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) --…

10 months ago

Jushi and Real Housewives Star Stacey Rusch Celebrate Successful Launch of Lifestyle Cannabis Brand Shayo

(Photo credit: Andreas Neumann) BOCA RATON, Fla., June 23, 2025 (GLOBE NEWSWIRE) --  Jushi Holdings Inc. (“Jushi” or the “Company”)…

10 months ago

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress

New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for…

10 months ago